SuperSonic Imagine Announces That Gordon Waldron Has Been Named Executive Vice President and CFO

AIX-EN-PROVENCE, France, November 16, 2010 - SuperSonic Imagine, the innovative ultrasound medical imaging company, is
pleased to announce Gordon Waldron has been named as Executive Vice President
and CFO. As a member of the board of directors, he will be responsible for
driving all of SuperSonic Imagine's key strategic and commercial partnerships
as well as overseeing the company's financial development plan.

Prior to joining SuperSonic Imagine in September 2010, Mr. Waldron spent
five years as CFO for the French biotech company Novexel where he raised 50
million euros in 2006, negotiated a preclinical license agreement which
brought the company a 75 million euros upfront payment in 2008 and directed a
trade sale process resulting in the acquisition of Novexel by AstraZeneca for
cash consideration of approximately $500 million in 2009.

Before Novexel, he spent eight years as VP Finance with Synt:em (Nimes,
France) where he raised 32 million euros in three financing rounds.

He also spent five years with Texas Instruments, first as Finance
Director for a French subsidiary, then as Group Finance Manager (based in the
UK) covering 17 entities and a distributor network for Texas Instruments
Software in Europe, the Middle East and Africa.

Mr. Waldron started his career with Spie Batignolles at the Head Office
near Paris before becoming a controller of the company's US subsidiaries
based in Pittsburgh.

He graduated from Duke University (USA) in 1988 and has both American and
British nationalities.

Mr. Waldron commented, "I am pleased to join such a high caliber group of
people working in such an innovative environment. This mix has already
produced some impressive R&D achievements as the company quickly
differentiated itself through the creation of a software based ultrasound
technology. The Aixplorer(R) MultiWave(TM) Ultrasound system not only offers
exceptional image quality but also has the unique ability to provide tissue
elasticity assessment which is fully reproducible and independent of the
user's experience, skill and scanning technique. The next chapter will be to
leverage this R&D excellence through commercial alliances and to extend
applications for the Aixplorer platform from breast alone to multiple other
organs."

SuperSonic Imagine Founder and CEO, Dr. Jacques Souquet (PhD.) remarked,
"We have built a very strong management team at SuperSonic Imagine and having
someone of Gordon's experience and stature enhances our capabilities. In
today's global business environment and particularly in medical imaging,
having the ability to drive strategic partnerships is critical. Gordon brings
this and other know-how to the company and will be a great asset."

About SuperSonic Imagine:

Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine
is an innovative, multinational medical imaging company dedicated to
developing a revolutionary ultrasound system: the Aixplorer(R). The system
leverages a unique MultiWave(TM) technology that enables the user to detect,
characterize and, in the future, treat palpable and non-palpable masses.
Engineers from all over the world have joined the SuperSonic Imagine team and
the company now has offices in Aix-en-Provence, Seattle, London and Munich.
SuperSonic Imagine holds the exclusive rights to 25 international patients
and submissions in diagnostic imaging and therapy applications that are
solely owned and solely used by the company.

For further information about SuperSonic Imagine please visit our
website: www.supersonicimagine.fr. www.supersonicimagine.com

Michele Debain, Marketing Director of SuperSonic Imagine, +33-442992432, michele.debain at supersonicimagine.fr; or Dan Conley of Beacon Communications, +1-312-593-8461, dconley at beaconpr.com, for SuperSonic Imagine